Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study
So you've got L-theanine slamming the brakes on those overwhelming feelings and ashwagandha keeping your daily cortisol levels on point and helping you sleep at night
doi: 10.3109/0284186X.2012.741326 14
Functional outcomes such as changes in mobility as measured by gait speed over 10 meters [also see (262)], as well as measures of cognitive impairment
L-carnitine supplementation mitigated these mitochondrial alterations, restored mtDNA levels, and enhanced -oxidation capacity (43, 72, 73)
With substantial weight loss demonstrated in Phase II trials and an acceptable safety profile, retatrutide may emerge as a leading treatment option pending Phase III trial results and FDA approval, anticipated in 2026